QT Imaging and Trimedyne Compared in Business Review

Analysis of two small-cap tech companies and which is the better investment

Feb. 26, 2026 at 8:34pm

Got story updates? Submit your updates here. ›

A comparison of QT Imaging (NASDAQ:QTI) and Trimedyne (OTCMKTS:TMED), two small-cap computer and technology companies, to determine which is the better investment based on factors like revenue, earnings, profitability, institutional ownership, and analyst recommendations.

Why it matters

This analysis provides insight into the relative strengths and weaknesses of these two small-cap tech firms, which can help investors make more informed decisions about where to allocate their capital in the sector.

The details

The article compares QT Imaging and Trimedyne across several key metrics, including revenue, earnings per share, valuation, net margins, return on equity, return on assets, institutional ownership, insider ownership, stock volatility, and analyst recommendations. Overall, the analysis finds that QT Imaging outperforms Trimedyne on 6 out of 10 factors compared.

  • The article was published on February 26, 2026.

The players

QT Imaging Holdings, Inc.

A company that engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers the QT Ultrasound Breast Scanner, an ultrasonic imaging system.

Trimedyne, Inc.

A company that manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field, including for orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, and other medical specialties.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the relative strengths and weaknesses of QT Imaging and Trimedyne, providing investors with valuable information to consider when evaluating these two small-cap tech companies as potential investment opportunities.